Botulinum toxin in the control of bruxism
DOI:
https://doi.org/10.33448/rsd-v12i11.43879Keywords:
Bruxism; Botulinum toxins, type A; Face.Abstract
Botulinum toxin is a therapeutic substance widely used in dentistry, especially in the area of orofacial harmonization. In orofacial harmonization procedures, botulinum toxin has proven to be an effective treatment in treating facial asymmetries, perioral wrinkles and relieving bruxism. Furthermore, its potential to relax the chewing muscles can contribute to the reduction of chronic facial pain and temporomandibular disorders, improving patients' quality of life. However, it is essential that such procedures are carried out by qualified professionals to ensure safety and effectiveness. Bruxism, in turn, is a neuromuscular disorder characterized by the involuntary clenching or grinding of teeth, mainly during sleep, but also during the day. Its multifactorial etiology and clinical implications that go beyond dental health, such as headaches, temporomandibular disorders, tooth wear and sleep disorders, make bruxism an intriguing phenomenon for health professionals. Although the exact cause of bruxism is not fully understood, factors such as stress, anxiety, malocclusion and neurological abnormalities are associated with its manifestation. Accurate diagnosis and an appropriate therapeutic approach are fundamental to its management, including behavioral therapies, oral devices and, in some cases, pharmacological interventions. In-depth research into bruxism is crucial to mitigating its adverse impacts on the oral health and general well-being of affected individuals. Therefore, the objective of this narrative literature review study is to investigate the potential use of botulinum toxin as an adjuvant treatment in orofacial harmonization.
References
Albrecht, P. et al. (2019). Alta prevalência de anticorpos neutralizantes após terapia de neurotoxina botulínica de longo prazo. Neurologia, 92, E48–E54.
Alonso-Navarro, H., Jiménez-Jiménez, F. J., Plaza-Nieto, J. F., et al. (2011). Tratamiento del bruxismo grave con toxina botulínica tipo A. Rev. Neurol, 53, 73-76.
Anandan, C., & Jankovic, J. (2021). Botulinum Toxin in Movement Disorders: An Update. Toxins, 13(1), 42.
Borba, A., Matayoshi, S., & Rodrigues, M. (2022). Avoiding Complications on the Upper Face Treatment With Botulinum Toxin: A Practical Guide. Aesthetic plastic surgery, 46(1), 385–394.
Bulanda, S., Ilczuk-Rypuła, D., Nitecka-Buchta, A., Nowak, Z., Baron, S., & Postek-Stefańska, L. (2021). Sleep Bruxism in Children: Etiology, Diagnosis, and Treatment-A Literature Review. International journal of environmental research and public health, 18(18), 9544.
Chen, Y., Tsai, C. H., Bae, T. H., Huang, C. Y., Chen, C., Kang, Y. N., & Chiu, W. K. (2023). Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Aesthetic plastic surgery, 47(2), 775–790.
Choudhury, S., Baker, M. R., Chatterjee, S., & Kumar, H. (2021). Botulinum Toxin: An Update on Pharmacology and Newer Products in Development. Toxins, 13(1), 58.
Faria, A. R. de, Suguíhara, R. T., & Muknicka, D. P. (2023). Botulinum toxin: Intercurrences and complications in the application. Research, Society and Development, 12(7), e14912742697.
Fernández-Núñez, T., Amghar-Maach, S., & Gay-Escoda, C. (2019). Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(4), e416–e424.
Francisco Filho, M. L., Suguíhara, R. T., & Muknicka, D. P. (2023). Mechanisms of action and indication of Botulinum Toxin. Research, Society and Development, 12(6), e15712642223.
Goldstein, G., DeSantis, L., & Goodacre, C. (2021). Bruxism: Best Evidence Consensus Statement. Journal of prosthodontics, 30(S1), 91–101.
Guarda-Nardini, L., et al. (2008). Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio, 26(2), 126-135.
Ihde, S., Konstantinovick, VS. (2007). O uso terapêutico da toxina botulínica em condições cervicais e maxilofaciais: uma revisão baseada em evidências. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104, e1-11.
Kaya, D. I., & Ataoglu, H. (2021). Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study. Nigerian journal of clinical practice, 24(3), 412–417.
Kwon, K. H., Shin, K. S., Yeon, S. H., & Kwon, D. G. (2019). Application of botulinum toxin in maxillofacial field: part I. Bruxism and square jaw. Maxillofacial plastic and reconstructive surgery, 41(1), 38.
Kwon, T.G. (2016). Botulinum toxin related research in maxillofacial plastic and reconstructive surgery. Maxillofac Plast Reconstr Surg, 38(1), 34.
Lobbezoo, F., Ahlberg, J., Raphael, K. G., Wetselaar, P., Glaros, A. G., Kato, T., Santiago, V., Winocur, E., De Laat, A., De Leeuw, R., Koyano, K., Lavigne, G. J., Svensson, P., & Manfredini, D. (2018). International consensus on the assessment of bruxism: Report of a work in progress. Journal of oral rehabilitation, 45(11), 837–844.
Luconi, E., Togni, L., Mascitti, M., Tesei, A., Nori, A., Barlattani, A., Procaccini, M., & Santarelli, A. (2021). Bruxism in Children and Adolescents with Down Syndrome: A Comprehensive Review. Medicina (Kaunas, Lithuania), 57(3), 224.
Mccall, W.D. Jr, Kim, Y.K., Chung, S.C., Chung, J.W. (2010). Effect of botulinum toxin injection on nocturnal bruxism: a randomized controlled trial. Am J Phys Med Rehabil, 89(1), 16-23.
Melo, G., Duarte, J., Pauletto, P., Porporatti, A. L., Stuginski-Barbosa, J., Winocur, E., Flores-Mir, C., & De Luca Canto, G. (2019). Bruxism: An umbrella review of systematic reviews. Journal of oral rehabilitation, 46(7), 666–690.
Monroy, P.G., Da Fonseca, M.A. (2006). Uso da toxina botulínica-A no tratamento do bruxismo severo em paciente com autismo: relato de caso. Dentista Spec Care, 26, 37-39.
Patel, J., Cardoso, J. A., & Mehta, S. (2019). A systematic review of botulinum toxin in the management of patients with temporomandibular disorders and bruxism. British dental journal, 226(9), 667–672.
Penna, C. B., Suguíhara, R. T., & Muknicka, D. P. (2023). Botulinum toxin in orofacial harmonization. Research, Society and Development, 12(7), e4312742506.
Rogoshin, A., Pang, Kk., Bukharaeva, E., Young, C., Slater, Cr. (2008). Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A. J Physiol, 586(13), 3163-3182.
Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).
Sener, H. O., Oral, N., Key, F. (2007). Intramasseteric botulinum toxin injection is as effective as oral overnight splint in nocturnal bruxism. Cephalalgia, 27(10), 1191.
Serrera-Figallo, M. A., Ruiz-de-León-Hernández, G., Torres-Lagares, D., Castro-Araya, A., Torres-Ferrerosa, O., Hernández-Pacheco, E., & Gutierrez-Perez, J. L. (2020). Use of Botulinum Toxin in Orofacial Clinical Practice. Toxins, 12(2), 112.
Shim, Y. J., Lee, H. J., Park, K. J., Kim, H. T., Hong, I. H., & Kim, S. T. (2020). Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo-Controlled Trial. Toxins, 12(3), 168.
Tan, Ek., Jankovic, J. (2000). Tratamento do bruxismo grave com toxina botulínica. J Am Dent Assoc, 131, 211-216.
Vavrina, J., & Vavrina, J. (2020). Bruxismus: Einteilung, Diagnostik und Behandlung [Bruxism: Classification, Diagnostics and Treatment]. Praxis, 109(12), 973–978.
Vieira, A. A. de P., Suguíhara, R. T., & Muknicka, D. P. (2023). Coadjuvant treatment of botulinum toxin in bruxism. Research, Society and Development, 12(8), e1512842852.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Valdêmia Cerqueira Muniz de Souza; Roberto Teruo Suguihara; Daniella Pilon Muknicka
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
